首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1741134

白血病筛检市场按检测类型、疾病类型、年龄层、最终用户和地区划分

Leukemia Screening Market, By Test Type, By Disease Type, By Age Group, By End User, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年白血病筛检市场规模估计为 83.4 亿美元，预计到 2032 年将达到 133.9 亿美元，2025 年至 2032 年的复合年增长率为 7%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	83.4亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	7.00%	2032年价值预测	133.9亿美元

白血病是一种影响血球的癌症。白血病是一种严重的疾病，会导致大量死亡，并给家庭和医疗保健系统带来沉重的负担。诊断白血病的主要方法是实验室检查和身体检查。全血球计数 (CBC) 可以检查体内红血球、白血球和血小板的水平。异常白血球水平过高可能提示患有白血病。某些类型的白血病细胞在血液中循环，而另一些则留在骨髓中，不会在常规血液检查中显示。由于全球各种白血病发病率的上升，全球白血病筛检市场在过去几年中经历了显着增长。白血病是一种起源于骨髓的血癌，会导致大量异常白血球的产生。由于环境污染加剧、生活方式改变以及全球人口老化，白血病患者的数量正在稳步增加。因此，已开发国家和开发中国家对用于早期发现白血病的先进筛检检测的需求日益增长。各种旨在提高公众对白血病认识和推广创新筛检解决方案的公共和私营部门倡议，正在进一步推动全球白血病筛检产业的发展。

市场动态：

由于退伍军人菌和肺炎相关疾病的盛行率不断上升、对快速先进诊断方法的需求日益增长以及细菌检测技术的市场发展等因素，市场正在显着扩张。退伍军人菌肺炎是一种相对罕见的社区型肺炎原因。例如，根据2022年11月发表的一项题为《社区获得性肺炎》的研究，预计全球社区获得性肺炎的发生率为每年每千人1.5至14例，地理、季节和人口特征都是影响因素。发病率随年龄增加，美国每年每10,000名成年人中有24.8例发生。

本研究的主要特点

本报告对全球白血病筛检市场进行了详细分析，并提供了预测期 2025-2032 的市场规模和年复合成长率（CAGR%）（假设 2024 年为基准年）。
它还揭示了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、绩效和策略等参数，介绍了全球白血病筛检市场的主要企业概况。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球白血病筛检市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员可以透过用于分析全球白血病筛检市场的各种策略矩阵来促进决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 8.34 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.00%	2032 Value Projection:	USD 13.39 Bn

Leukemia is a type of cancer that affects blood cells. It is a serious condition that causes a high number of deaths, thereby creating a huge burden on families and the healthcare system. The main diagnostic tools for leukemia are laboratory tests and a physical exam. A complete blood count (CBC) checks the levels of red and white blood cells and platelets in the body. A high level of abnormal white cells can indicate leukemia. Some types of leukemia cells circulate in the blood, while others stay in the bone marrow and do not show up in a routine blood test. The global leukemia screening market has been witnessing notable growth over the past few years due to the rising incidence of different types of leukemia across the world. Leukemia is a type of blood cancer that starts in the bone marrow and results in a high number of abnormal white blood cells. There has been steady rise in leukemia cases due to growing environmental pollution, changing lifestyle habits, and increasing age of the population globally. As a consequence, demand for advanced screening tests for early detection of leukemia has increased in both developed and developing nations. Various public and private initiatives aimed at enhancing awareness about leukemia and availability of innovative screening solutions has further propelled the global leukemia screening industry.

Market Dynamics:

The market is expanding significantly as a result of factors such the increased prevalence of illnesses linked to legionella and pneumonia, as well as the growing need for quick, sophisticated diagnostic methods and developments in bacterial testing technology. A comparatively rare cause of community-acquired pneumonia is legionella pneumonia. For instance, in November 2022, according to a study published titled Community-Acquired Pneumonia, the expected global incidence of community-acquired pneumonia ranges from 1.5 to 14 cases per 1000 person each year, with region, season, and population characteristics all having a part. Incidence rates rise with age, with 24.8 instances per 10,000 adults in the U.S. each year.

Key features of the study:

This report provides in-depth analysis of the global leukemia screening market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global leukemia screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., QIAGEN N.V., Beckman Coulter, Inc., Adaptive Biotechnologies Corporation, Invivoscribe, Inc., and ArcherDX, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global leukemia screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leukemia screening market

Detailed Segmentation:

By Test Type
- Complete Blood Count (CBC)
- Bone Marrow Aspiration and Biopsy
- Flow Cytometry
- Cytogenetic Analysis
- Polymerase Chain Reaction (PCR)
- Immunophenotyping
- Others
By Disease Type
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myeloid Leukemia (CML)
- Others
By Age Group
- Pediatric
- Adult
- Geriatric
By End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Others
By Region
- North America
- Europe
- Latin America
- Middle East
- Africa
Company Profiles
- F.Hoffmann-La Roche Ltd
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Sysmex Corporation
- Bio-Rad Laboratories, Inc.
- QIAGEN N.V.
- Beckman Coulter, Inc.
- Adaptive Biotechnologies Corporation
- Invivoscribe, Inc.
- ArcherDX, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By Disease Type
- Market Snippet, By Age Group
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing incidence of leukemia
- High cost of screening procedures
- Expansion in emerging markets
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Leukemia Screening Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Leukemia Screening Market, By Test Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Complete Blood Count (CBC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Bone Marrow Aspiration and Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Flow Cytometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cytogenetic Analysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Immunophenotyping
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Leukemia Screening Market, By Disease Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Acute Lymphoblastic Leukemia (ALL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
Acute Myeloid Leukemia (AML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
Chronic Lymphocytic Leukemia (CLL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
Chronic Myeloid Leukemia (CML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )

7. Global Leukemia Screening Market, By Age Group, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )

8. Global Leukemia Screening Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Leukemia Screening Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
  - South Africa
  - Central Africa
  - North Africa

10. Competitive Landscape

Company Profile
- F.Hoffmann-La Roche Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Abbott Laboratories
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Thermo Fisher Scientific Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Sysmex Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Bio-Rad Laboratories, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- QIAGEN N.V.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Beckman Coulter, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Adaptive Biotechnologies Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Invivoscribe, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- ArcherDX, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views

11. Section

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

白血病筛检市场按检测类型、疾病类型、年龄层、最终用户和地区划分